JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia (Q79412057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

juvenile myelomonocytic leukemia

22 December 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Gaetano Bergamaschi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Henrik Hasle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Andrea Pession

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Kratz C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Bergsträsser E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Danesino C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

De Filippi P

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Lisini D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Locatelli F

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sainati L

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Starý J

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Trebo M

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

van den Heuvel-Eibrink M

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Wójcik D

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Niemeyer CM

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

7 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

367-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17151700%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404484

22 December 2019

exact match

0 references

cites work

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

JAK2 Val617Phe activating tyrosine kinase mutation in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021

Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404484

7 January 2021